These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35327617)

  • 21. Functional differences in the mu opioid receptor SNP 118A>G are dependent on receptor splice-variant and agonist-specific recruitment of β-arrestin.
    Patrick C; Ettah U; Nguyen V; Hart C; Atchley E; Mallela K; Scheinman RI; Monte AA
    Clin Transl Sci; 2024 Aug; 17(8):e13888. PubMed ID: 39118392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible involvement of prolonging spinal µ-opioid receptor desensitization in the development of antihyperalgesic tolerance to µ-opioids under a neuropathic pain-like state.
    Narita M; Imai S; Nakamura A; Ozeki A; Asato M; Rahmadi M; Sudo Y; Hojo M; Uezono Y; Devi LA; Kuzumaki N; Suzuki T
    Addict Biol; 2013 Jul; 18(4):614-22. PubMed ID: 21812868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons.
    Connor M; Bagley EE; Chieng BC; Christie MJ
    Br J Pharmacol; 2015 Jan; 172(2):492-500. PubMed ID: 24597632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remifentanil produces cross-desensitization and tolerance with morphine on the mu-opioid receptor.
    Nowoczyn M; Marie N; Coulbault L; Hervault M; Davis A; Hanouz JL; Allouche S
    Neuropharmacology; 2013 Oct; 73():368-79. PubMed ID: 23792280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic morphine treatment inhibits opioid receptor desensitization and internalization.
    Eisinger DA; Ammer H; Schulz R
    J Neurosci; 2002 Dec; 22(23):10192-200. PubMed ID: 12451120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
    Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Switching from morphine to fentanyl attenuates the decline of µ-opioid receptor expression in periaqueductal gray of rats with morphine tolerance.
    Dong YP; Sun L; Liu XY; Liu RS
    Chin Med J (Engl); 2013; 126(19):3712-6. PubMed ID: 24112169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of fentanyl on expression of mu-receptor and beta-arrestin 2 in periaqueductal gray of rats tolerant to morphine].
    Liu RS; Sun L; Liu XY; Li XY; Xu L
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(19):1356-60. PubMed ID: 19615194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid μ-opioid receptor desensitization.
    Miess E; Gondin AB; Yousuf A; Steinborn R; Mösslein N; Yang Y; Göldner M; Ruland JG; Bünemann M; Krasel C; Christie MJ; Halls ML; Schulz S; Canals M
    Sci Signal; 2018 Jul; 11(539):. PubMed ID: 30018083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in antinociceptive signalling mechanisms following morphine and fentanyl microinjections into the rat periaqueductal gray.
    Morgan MM; Tran A; Wescom RL; Bobeck EN
    Eur J Pain; 2020 Mar; 24(3):617-624. PubMed ID: 31785128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of Antinociceptive Cross-Tolerance With Co-Administration of Morphine and Fentanyl Into the Periaqueductal Gray of Male Sprague-Dawley Rats.
    Bobeck EN; Schoo SM; Ingram SL; Morgan MM
    J Pain; 2019 Sep; 20(9):1040-1047. PubMed ID: 30853505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling.
    Melief EJ; Miyatake M; Bruchas MR; Chavkin C
    Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11608-13. PubMed ID: 20534436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct pharmacological properties of morphine metabolites at G(i)-protein and β-arrestin signaling pathways activated by the human μ-opioid receptor.
    Frölich N; Dees C; Paetz C; Ren X; Lohse MJ; Nikolaev VO; Zenk MH
    Biochem Pharmacol; 2011 May; 81(10):1248-54. PubMed ID: 21396918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurokinin 1 receptors regulate morphine-induced endocytosis and desensitization of mu-opioid receptors in CNS neurons.
    Yu YJ; Arttamangkul S; Evans CJ; Williams JT; von Zastrow M
    J Neurosci; 2009 Jan; 29(1):222-33. PubMed ID: 19129399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain.
    Baker AK; Hoffmann VL; Meert TF
    Pharmacol Biochem Behav; 2002 Dec; 74(1):73-86. PubMed ID: 12376154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of morphine analgesic effect with induction of mu-opioid receptor endocytosis in rats.
    Hashimoto T; Saito Y; Yamada K; Hara N; Kirihara Y; Tsuchiya M
    Anesthesiology; 2006 Sep; 105(3):574-80. PubMed ID: 16931992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid tolerance: is there a dialogue between glutamate and beta-arrestin?
    Chiao YC; Wong CS
    Acta Anaesthesiol Taiwan; 2004 Jun; 42(2):93-101. PubMed ID: 15346705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Development of opioid tolerance -- molecular mechanisms and clinical consequences].
    Freye E; Latasch L
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):14-26. PubMed ID: 12522725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons.
    Dang VC; Christie MJ
    Br J Pharmacol; 2012 Mar; 165(6):1704-1716. PubMed ID: 21564086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recovery from mu-opioid receptor desensitization after chronic treatment with morphine and methadone.
    Quillinan N; Lau EK; Virk M; von Zastrow M; Williams JT
    J Neurosci; 2011 Mar; 31(12):4434-43. PubMed ID: 21430144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.